The Life Science Industry’s Largest Data and Business Process Platform for Therapy Commercialization and Access

IntegriChain is on a mission… to help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.

Proven Success at Making Life Sciences Data Actionable

More than a decade ago, IntegriChain pioneered channel data aggregation, data stewardship and governance as well as advanced analytics. Enhanced by data science, our solutions make specialty pharmacy, retail pharmacy, distributor and patient services data actionable.
With the help of private equity support, IntegriChain has expanded our business to include managed services and an application platform across key related disciplines including government pricing, rebate management and gross to net. We recently joined forces with Cumberland Life Sciences, a leading provider of contracts and pricing related managed services, advisory services, and system integration services.

IntegriChain now has the largest managed services platform in the industry, supporting more than 150 manufacturer customers every day. We also have grown team of world-class commercialization and market access experts to more than 370. Today, our global IntegriChain team is uniquely positioned to address critical therapy access challenges throughout the drug commercialization life cycle, ensuring that patients have access to their life-saving and life-changing medicines as needed and minimizing the chances that they forego therapy.

Trusted by World-Class Life Sciences Innovators of all Size

From improving launch readiness to enabling regulatory compliance and access to government programs as well as optimizing distribution and patient access strategies and programs, IntegriChain plays a vital role in enabling our customers to make better and faster payer, channel and patient support decisions. In fact, more than 220 life science manufacturers— ranging from pre-commercial manufacturers to Big Pharma and including 20 of the Top-20 companies rely on IntegriChain’s world-class data, managed and professional services. Together, we have participated in 71% of product launches over the past 2 years including 35 first launches. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm.

We are passionate about our customers’ mission – improving the lives of patients – and view it as our own.